×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Round Table Discussion: Interpretation of New Pharmacovigilance Regulations: Key Insights
Session Chair(s)
Jeremy Jokinen, PhD, MS
Vice President and Head, Safety Evidence and Sciences
Bristol-Myers Squibb Company, United States
Round table discussion tied to session #136: Interpretation of New Pharmacovigilance Regulations: Key Insights (Monday, June 24, 2:15-3:15PM). Seating is limited. To include special guests from the session: Ajay Singh, Jane Carroll.
Have an account?